Evidence map›Paper›PMID 37958700›Full record

ArticleInternational journal of molecular sciences2023

Top-Down Proteomics of Human Saliva, Analyzed with Logistic Regression and Machine Learning Methods, Reveal Molecular Signatures of Ovarian Cancer.

Francesca Scebba, Stefano Salvadori, Silvia Cateni, Paola Mantellini, Francesca Carozzi, Simonetta Bisanzi, Cristina Sani, Marzia Robotti, Ivana Barravecchia, Francesca Martella and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Francesca ScebbaHealth Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy.
Stefano SalvadoriInstitute of Clinical Physiology, National Research Council, Via G. Moruzzi, 1, 56124 Pisa, Italy.ORCID 0000-0002-1266-3931
Silvia CateniCenter for Information and Communication Technologies for Complex Industrial Systems and Processes (ICT-COISP), Telecommunications, Computer Engineering, and Photonics Institute (TeCIP), Scuola Superiore Sant'Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy.
Paola MantelliniIstituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Via Cosimo il Vecchio, 2, 50139 Firenze, Italy.
Francesca CarozziIstituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Via Cosimo il Vecchio, 2, 50139 Firenze, Italy.
Simonetta BisanziIstituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Via Cosimo il Vecchio, 2, 50139 Firenze, Italy.
Cristina SaniIstituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Via Cosimo il Vecchio, 2, 50139 Firenze, Italy.
Marzia RobottiPh.D. School in Translational Medicine, Scuola Superiore Sant'Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy.
Ivana BarravecchiaThe Institute of Biorobotics, Scuola Superiore Sant'Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy.
Francesca MartellaBreast Unit and SOC Oncologia Medica Firenze-Dipartimento Oncologico, Azienda Usl Toscana Centro, Ospedale Santa Maria Annunziata, Via dell'Antella, 58, 50012 Firenze, Italy.
Valentina CollaCenter for Information and Communication Technologies for Complex Industrial Systems and Processes (ICT-COISP), Telecommunications, Computer Engineering, and Photonics Institute (TeCIP), Scuola Superiore Sant'Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy.ORCID 0000-0002-9574-0575
Debora AngeloniHealth Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Via G. Moruzzi, 1, 56124 Pisa, Italy.
Scuola Superiore Sant'Anna · ITIstituto per lo Studio e la Prevenzione Oncologica · ITIstituto di Fisiologia Clinica · ITOspedale Santa Maria Annunziata · IT

Funding

Fondazione Cassa di Risparmio di Firenze 2014, SAPIDMinistry of Research MUR Italy PNR 2021 SAMARCANDA
6 · The paper itself

Abstract

Ovarian cancer (OC) is the most lethal of all gynecological cancers. Due to vague symptoms, OC is mostly detected at advanced stages, with a 5-year survival rate (SR) of only 30%; diagnosis at stage I increases the 5-year SR to 90%, suggesting that early diagnosis is essential to cure OC. Currently, the clinical need for an early, reliable diagnostic test for OC screening remains unmet; indeed, screening is not even recommended for healthy women with no familial history of OC for fear of post-screening adverse events. Salivary diagnostics is considered a major resource for diagnostics of the future. In this work, we searched for OC biomarkers (BMs) by comparing saliva samples of patients with various stages of OC, breast cancer (BC) patients, and healthy subjects using an unbiased, high-throughput proteomics approach. We analyzed the results using both logistic regression (LR) and machine learning (ML) for pattern analysis and variable selection to highlight molecular signatures for OC and BC diagnosis and possibly re-classification. Here, we show that saliva is an informative test fluid for an unbiased proteomic search of candidate BMs for identifying OC patients. Although we were not able to fully exploit the potential of ML methods due to the small sample size of our study, LR and ML provided patterns of candidate BMs that are now available for further validation analysis in the relevant population and for biochemical identification.

Indexed as

Ovarian NeoplasmsSalivaBiomarkers, TumorFemaleHumansLogistic ModelsMachine LearningProteomicsBiomarkers, Tumorbiomarkersbreast cancerlogistic regressionmachine learningmass spectrometryovarian cancerproteomicssalivaSELDI-TOF-MS

Identifiers

PMID37958700
PMCPMC10648137
OpenAlexW4388160306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.